Chagas' disease: IgG isotypes against cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens of Trypanosoma cruzi in chronic chagasic patients

Journal of Clinical Laboratory Analysis

Volumn 21, Issue 5, 2007, Pages 271-276

  Vercosa A F A ^a   Lorena, V M B ^a   Carvalho, C L ^a   Melo, M F A D ^a   Cavalcanti, M G A ^b   Silva, E D ^c   Ferreira, A G P ^c   Pereira, V R A ^a   Souza, W V ^a   Gomes, Yara M ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c Instituto de Technologia em Imunobiologicos   (Brazil)

Author keywords

Biological marker; Chagas' disease; Isotypic profile; Recombinant antigens; Trypanosoma cruzi

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; PARASITE ANTIGEN; RECOMBINANT ANTIGEN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHAGAS DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PROGNOSIS; TRYPANOSOMA CRUZI;

ADULT; AGED; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY FORMATION; ANTIGENS, PROTOZOAN; CHAGAS DISEASE; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 35048842719     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20186     Document Type: Article

References (31)

1. Gomes JAS, Bahia-Oliveira LMG, Rocha MOC, et al. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun 2005;73:7960-7966.
2. 2+ currents. Cardiovasc Res 2003;58:55-65.
3. Lorca M, Gonzalez A, Veloso C, Reyes V. Chagas' disease patients with Trypanosoma cruzi recombinant antigens. Am J Trop Med Hyg 1992;46:44-49.
4. Andrade ZA. Immunopathology of Chagas' disease. Mem Inst Oswaldo Cruz 1999;94:71-80.
5. World Health Organization (WHO). Control of Chagas disease. WHO Technical Report Series 2002. 905:109.
6. Oliveira JR. W Quadro Clínico: Fase Crônica - Forma Indeterminada. In: Malta J, editor. Doença de Chagas. São Paulo: Sarvier. 1996. p 43-47.
7. Castro C, Macedo V, Rezende JM, Prata A. Estudo radiológico longitudinal do esôfago, em área endêmica de doença de Chagas, em um período de 13 anos. Rev Soc Bras Med Trop 1994;27:227-233.
8. Motran CC, Serra HM, Gea SE, Vullo CM, Vottero-Cima E. Antibody isotypes profiles against Trypanosoma cruzi antigens in two Ameridian populations from a Chagas' disease endemic area. Acta Trop 1994;58:105-114.
9. Krieger MA, Almeida E, Oelemann W, et al. Use of recombinant antigens for the accurate immunodiagnosis of Chagas' disease. Am J Trop Med Hyg 1992;46:427-434.
10. Lafaille JJ, Linss J, Krieger MA, Souto-Padron T, De Souza W, Goldenberg S. Structure and expression of two Trypanosoma cruzi genes encoding antigenic proteins bearing repetitive epitopes. Mol Biochem Parasitol 1989;35:127-136.
11. Pereira VR, Lorena VMB, Nakazawa M, et al. Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection. Parasitol Res 2005;96:154-161.
12. Pereira VR, Lorena VMB, Nakazawa M, et al. Immunization with cytoplasmic repetitive antigen and flagellar repetitive antigen of Trypanosoma cruzi stimulates a cellular immune response in mice. Parasitology 2004;129:563-570.
13. Pereira VR, Lorena VMB, Verçosa AFA, et al. Antibody isotype responses in Balb/c mice immunized with the cytoplasmic repetitive antigen and flagellar repetitive antigen of Trypanosoma cruzi. Mem Inst Oswaldo Cruz 2003a;98:823-825.
14. Pereira VR, Lorena VMB, Nakazawa M, et al. Evaluation of the immune response to CRA and FRA recombinant antigens of Trypanosoma cruzi in C57BL/6 mice. Rev Soc Bras Med Trop 2003b;36:435-440.
15. Gadelha AAM, Verçosa AFA, Lorena VMB, et al. Chagas' disease diagnosis: comparative analysis of recombinant ELISA with conventional ELISA and hemagglutination tests. Vox Sang 2003;85:165-170.
16. Silva ED, Pereira VRA, Gomes JAS, et al. Use of the EIE-Recombinant- Chagas-Biomanguinhos kit to monitor cure of human Chagas' disease. J Clin Lab Anal 2002;16:132-136.
17. Gomes YM, Pereira VRA, Nakazawa M, et al. Serodiagnosis of chronic Chagas' disease by using EIE-Recombinante-Chagas-Biomanguinhos kit. Mem Inst Oswaldo Cruz 2001;96:497-501.
18. Pereira-Chioccola VL, Fragata-Filho AA, Levy AM, Rodrigues MM, Schenkman S. Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment. Clin Diagn Lab Immunol 2003;10:826-830.
19. Brodskyn CI, Barral-Netto M. Resposta Imune na Doença de Chagas. In: Brener Z, Andrade ZA, Barral-Netto M, editors. Trypanosoma cruzi e Doença de Chagas. Rio de Janeiro: Guanabara Koogan; 2000. p 170-176.
20. Krettli AU, Brener Z. Protective effect of specific antibodies in Trypanosoma cruzi infections. J Immunol 1976;116:755-760.
21. Krettli AU, Brener Z. Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies. J Immunol 1982;128:2009-2012.
22. Sterin-Borda L, Goin JC, Bilder CR, Iantorno G, Hernando AC, Borda E. Interaction of human chagasic IgG with human colon muscarinic acetylcholine receptor: molecular and functional evidence. Gut 2001;49:699-705.
23. Morgan J, Dias JCP, Gontijo ED, et al. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease. Am J Trop Med Hyg 1996;55:355-359.
24. Cordeiro FD, Martins-Filho O, Rocha MOC, Adad S, Corrêa-Oliveira R, Romanha JA. Anti-Trypanosoma cruzi immunoglobulin IgG1 can be a useful tool for diagnosis and prognosis of human Chagas' disease. Clin Diagn Lab Immunol 2001;8:112-118.
25. Michailowsky V, Luhrs K, Rocha MOC, Fouts D, Gazzinelli RT, Manning JE. Humoral and cellular immune responses to Trypanosoma cruzi-derived Paraflagellar Rod Proteins in patients with Chagas' disease. Infect Immun 2003;71:3165-3171.
26. Romeiro SA, Takehara HA, Mota I. Isotype of lytic antibodies in serum of Chagas' disease patients. Clin Exp Immunol 1984;55:413-418.
27. Gusmào RD'A, Rezende JM, Rassi A, Gam AA, Neve FA. Antibody levels to Trypanosoma cruzi in infected patients with and without evidence of chronic Chagas' disease. Am J Trop Med Hyg 1982;31:452-458.
28. Zauza PL, Borges-Pererira J. Níveis séricos de IgG anti-T cruzi na evolução da cardiopatia chagásica, no período de 10 anos. Rev Soc Bras Med Trop 2001;4:399-405.
29. Hernández-Becerril N, Nava A, Reys PA, Monteon VM. IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients. Arch Cardiol Mex 2001;71:199-205.
30. Dutra WO, Rocha MOC, Teixeira MM. The clinical immunology of human Chagas disease. Trends Parasitol 2005;21:581-587.
31. Gazzinelli RT, Gazzinelli G, Cancado JR, Cardoso JE, Brener Z, Colley DG. Two models of idiotypic stimulation of T lymphocytes from patients with Chagas' disease: correlations with clinical forms of infection. Res Immunol 1990;141:757-770.